Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuangang Su

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|November 21, 2025
Transcriptomic analysis reveals TME-mediated macrophage IFIT1 upregulation and CX3CR1 suppression drive osteosarcoma progressionKeyi Wang, Huanyang He, Jiamin Liang, et al.
Annals of Hematology|February 13, 2026
Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screeningYing Gui, Weiwei Chen, Yuangang Su, et al.
Current Genomics|February 13, 2023
Comparisons of Forecasting for Survival Outcome for Head and Neck Squamous Cell Carcinoma by using Machine Learning Models based on Multi-omicsLiying Mo, Yuangang Su, Jianhui Yuan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 23, 2025
Schisandrol B inhibits osteoclastogenesis and mitigates estrogen deficiency-induced bone loss by targeting TRAF6-NOX1 pathwayYuangang Su, Jiamin Liang, Haoyu Lian, et al.
Stem Cell Research & Therapy|December 30, 2025
Carnosic acid serves as a dual Nrf2 activator and PTEN/AKT suppressor to inhibit traumatic heterotopic ossificationDonglei Wei, Dezhi Song, Hui Wang, et al.
ACS Omega|August 12, 2024
Regorafenib Attenuates Osteoclasts Differentiation by Inhibiting the NF-κB, NFAT, ERK, and p38 Signaling PathwaysLin Zhou, Peiru Su, Xiangya Luo, et al.
Free Radical Biology & Medicine|January 17, 2023
Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activationYinglong Xu, Dezhi Song, Xixi Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 6, 2023
Aminooxyacetic acid hemihydrochloride leads to decreased intracellular ATP levels and altered cell cycle of prostate cancer cells by suppressing energy metabolismHailong Teng, Biao Yang, Yuangang Su, et al.
Biochemical Pharmacology|December 12, 2023
Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activationXiaoliang Feng, Zhijuan Liu, Yuangang Su, et al.
Cell Death Discovery|February 17, 2024
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathwaysKai Gan, Haoyu Lian, Tao Yang, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|November 21, 2025
Transcriptomic analysis reveals TME-mediated macrophage IFIT1 upregulation and CX3CR1 suppression drive osteosarcoma progressionKeyi Wang, Huanyang He, Jiamin Liang, et al.
Annals of Hematology|February 13, 2026
Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screeningYing Gui, Weiwei Chen, Yuangang Su, et al.
Current Genomics|February 13, 2023
Comparisons of Forecasting for Survival Outcome for Head and Neck Squamous Cell Carcinoma by using Machine Learning Models based on Multi-omicsLiying Mo, Yuangang Su, Jianhui Yuan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 23, 2025
Schisandrol B inhibits osteoclastogenesis and mitigates estrogen deficiency-induced bone loss by targeting TRAF6-NOX1 pathwayYuangang Su, Jiamin Liang, Haoyu Lian, et al.
Stem Cell Research & Therapy|December 30, 2025
Carnosic acid serves as a dual Nrf2 activator and PTEN/AKT suppressor to inhibit traumatic heterotopic ossificationDonglei Wei, Dezhi Song, Hui Wang, et al.
ACS Omega|August 12, 2024
Regorafenib Attenuates Osteoclasts Differentiation by Inhibiting the NF-κB, NFAT, ERK, and p38 Signaling PathwaysLin Zhou, Peiru Su, Xiangya Luo, et al.
Free Radical Biology & Medicine|January 17, 2023
Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activationYinglong Xu, Dezhi Song, Xixi Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 6, 2023
Aminooxyacetic acid hemihydrochloride leads to decreased intracellular ATP levels and altered cell cycle of prostate cancer cells by suppressing energy metabolismHailong Teng, Biao Yang, Yuangang Su, et al.
Biochemical Pharmacology|December 12, 2023
Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activationXiaoliang Feng, Zhijuan Liu, Yuangang Su, et al.
Cell Death Discovery|February 17, 2024
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathwaysKai Gan, Haoyu Lian, Tao Yang, et al.
Pageof 5